Monoclonal gammopathy of undetermined significance versus smoldering myeloma: is active surveillance enough?

Semin Oncol. 2011 Jun;38(3):327-34. doi: 10.1053/j.seminoncol.2011.03.019.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Disease Progression
  • Humans
  • Male
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance / pathology*
  • Monoclonal Gammopathy of Undetermined Significance / therapy*
  • Multiple Myeloma / prevention & control*
  • Observation
  • Paraproteinemias / pathology*
  • Paraproteinemias / therapy*